UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of October 2006 (October 10, 2006)

Commission File Number: 0-15850

ANSELL LIMITED

(Translation of registrant’s name into English)

Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  x            Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨            No  x

This Form 6-K contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended, and information that is based on management’s beliefs as well as assumptions made by and information currently available to management. When used in this Form 6-K, the words “anticipate,” “approach,” “begin,” believe,” “continue,” “expect,” “forecast,” “going forward,” “improved,” “likely,” “look forward,” “opportunity,” “outlook,” “plans,” “potential,” “proposal,” “should” and “would” and similar expressions are intended to identify forward-looking statements. These forward-looking statements necessarily make assumptions, some of which are inherently subject to uncertainties and contingencies that are beyond the Company’s control. Should one or more of these uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, expected, estimated or projected. Specifically, the ability of the Company to realize its ongoing commitment to increasing shareholder value through its ongoing restructuring, asset dispositions, strategic review and implementation, and cost cutting initiatives, may be affected by many factors including: uncertainties and contingencies such as economic conditions both in the world and in those areas where the Company has or will have substantial operations; foreign currency exchange rates; pricing pressures on products produced by its subsidiaries; growth prospects; positioning of its business segments; future productions output capacity; and the success of the Company’s business strategies, including further structural and operational changes, business dispositions, internal reorganizations, cost cutting, and consolidations.

1 Ansell Limited Ansell Limited Business Overview - Business Overview - October 2006 October 2006 Doug Tough  – Doug Tough  – Chief Executive Officer Chief Executive Officer Rustom Jilla – Rustom Jilla – Chief Financial Officer Chief Financial Officer

2 Agenda Agenda 1. 1. Overview Overview - - Doug Tough Doug Tough 2. 2. Results Results - - Rustom Jilla Rustom Jilla 3. 3. Strategic Focus Strategic Focus - - Doug Tough Doug Tough FORWARD-LOOKING STATEMENTS This presentation contains forward-looking  statements within the meaning of the Securities Exchange Act of 1934 as amended,  and information that is based on management’s beliefs as well as assumptions  made by and information currently available to management. When used in this presentation, the words “anticipate,” “approach,” “begin,” believe,” “continue,” “expect,” “forecast,” “going  forward,” “improved,” “likely,” “look forward,” “opportunity,” “outlook,” “plans,” “potential,” “proposal,” “should” and “would” and similar expressions  are intended to identify forward-looking statements. These forward-looking statements  necessarily make assumptions, some of which are inherently subject to  uncertainties and contingencies that are beyond the Company’s control. Should one or more of these  uncertainties materialize, or should underlying assumptions prove incorrect,  actual results may vary materially from those anticipated, expected, estimated  or projected.

3 Overview Overview Doug Tough Doug Tough

4 Who is Ansell? Who is Ansell? A 101+ year old company A world leader in healthcare barrier protection products and services An Australian (ASX) listed Company (ANN), with market capitalization ~US$1.1 billion Sales of ~US$850 million and over 11,000 employees in 26 countries Statutory HQ in Australia, Operating HQ in the US, Asian Regional HQ in Melbourne, with manufacturing headquarters in Shah Alam, Malaysia 85% of sales in Europe and N. America and most plants in Asia & Mexico Asian Plants in Malaysia (3), Thailand (2), Sri Lanka (1) and India (3) Operating currency is the USD (which is used in this presentation unless otherwise noted) Filings - Australian Statutory Report and US SEC 20F Corporate website – www.ansell.com Ratings Long Term Short Term Outlook Standard & Poor’s BB+ B Positive Moody’s Baa3 P3 Stable

5 A Global Leader A Global Leader Occupational Gloves (Synthetics) Occupational Gloves (Synthetics) Market: ~US$2.1B Market: ~US$2.1B 2006 2006 #1 Ansell #1 Ansell ~20% ~20% Consumer (Condoms) Consumer (Condoms) Market: ~US$0.9B Market: ~US$0.9B 2006 2006 #3 Ansell   #3 Ansell   ~11% ~11% Estimated global market size and positions Estimated global market size and positions Surgical Gloves Surgical Gloves Market: ~US$0.6B Market: ~US$0.6B 2006 2006 #2 Ansell #2 Ansell ~ 24% ~ 24% Exam Gloves (Excluding Exam Gloves (Excluding Occupational) Occupational) Market: ~US$1.0B Market: ~US$1.0B 2006 2006 #2 Ansell #2 Ansell ~ 8% ~ 8% Source: Nielsen, IMS, and internal estimates

6 Our Products Our Products

7 Diversified Key Customers Diversified Key Customers Companies: industrial, auto, Companies: industrial, auto, chemicals, food etc. chemicals, food etc. Hospitals/Medical Centres; Hospitals/Medical Centres; acute and alternate care, acute and alternate care, first responders etc first responders etc Retail: food stores, drug Retail: food stores, drug stores, convenience stores, stores, convenience stores, mass merchandisers mass merchandisers

8 Ansell Regions – Ansell Regions – F’06 F’06 SEGMENT EBIT  ($M) = 107.6 SEGMENT EBIT  ($M) = 107.6 SALES ($M) = 849.1 SALES ($M) = 849.1 16% 16% 37% 37% 47% 47% 43% 43% 25% 25% 32% 32% Asia Pacific 133.2 Europe 313.7 Americas 402.2 Asia Pacific 27.3 Americas 46.4 Europe 33.9

9 Manufacturing Facilities Manufacturing Facilities 80% in Asia 80% in Asia 12% in Mexico 12% in Mexico 5% in North America 5% in North America 3% in Europe 3% in Europe Americas & UK  Americas & UK  Chemical Resistant Chemical Resistant General Purpose General Purpose Specialty Specialty High spec knitted High spec knitted Outsource ~US$150 M Outsource ~US$150 M Exam gloves Exam gloves Occupational gloves Occupational gloves Malaysia  Premium Surgical Premium Surgical Powder Free Exam Powder Free Exam Powdered Exam Powdered Exam Household gloves Household gloves Primary R&D facility near KL Primary R&D facility near KL Thailand  Thailand  Condoms Condoms Powder Free Exam Powder Free Exam Household gloves Household gloves Synthetic Exam Synthetic Exam India & Sri Lanka  India & Sri Lanka  Standard & Premium Surgical Condoms Powder Free Exam General Purpose Chemical Resistant Critical Environment 80% in Asia 80% in Asia 12% in Mexico 12% in Mexico 5% in North America 5% in North America 3% in Europe 3% in Europe Americas & UK  Americas & UK  Chemical Resistant Chemical Resistant General Purpose General Purpose Specialty Specialty High spec knitted High spec knitted Outsource ~US$150 M Outsource ~US$150 M Exam gloves Exam gloves Occupational gloves Occupational gloves Premium Surgical Premium Surgical Powder Free Exam Powder Free Exam Powdered Exam Powdered Exam Household gloves Household gloves Primary R&D facility near KL Primary R&D facility near KL Thailand  Thailand  Condoms Condoms Powder Free Exam Powder Free Exam Household gloves Household gloves Synthetic Exam Synthetic Exam India & Sri Lanka  80% in Asia 12% in Mexico 5% in North America 3% in Europe Americas & UK  Chemical Resistant General Purpose Specialty High spec knitted Outsource ~US$150 M Exam gloves Occupational gloves Premium Surgical Powder Free Exam Powdered Exam Household gloves Primary R&D facility near KL Thailand  Condoms Powder Free Exam Household gloves Synthetic Exam Employees (11,000 approx.)

10 Results Results Rustom Jilla Rustom Jilla

11 AUD  +64% USD AUD $10.04 $7.65 USD  +80% ASX200  +67% 30 June 05 30 June 04 31 Dec 04 F’04 TSR 34% F’05 TSR 32% 1  July 03 31 Dec 03 ASX 200 Total Shareholder Return Total Shareholder Return $7.74 $5.90 $3.99 $5.35 3,039 3,533 31 Dec 05 4,278 Dividends                              A13¢ A17¢ A21¢ Total Shareholder Return (TSR) = Share Price appreciation plus dividends Share Price 29 Sept 06 30 June 06 F’06 TSR -1% $9.67 $7.18 5,074 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 11.5 12 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 11.5 12

12 Key Financial Metrics Key Financial Metrics EPS - US$ ROE % ROA (HC only)% Gearing % EBIT % Gross Margin % Free Cash Flow Profit Attributable $M Sales $M F’05 was 41.1 ¢ pre AIFRS 57 ¢ 60 ¢ 18.2 18.7 18.0 23.2 After SPT sale, buybacks, dividends 10.8 19.1 12.1 13.5 Latex, sales mix 37.4 40.1 Average WC days from 85 to 80 76.7 94.5 DTA  90.8 101.0 +4.6% despite USD headwinds 849.1 812.1 F’06 F’05 • The impact of write-downs (-$60.9M in F’05, -$4.1M in F’06) in the since divested South Pacific Tyres investment are excluded from the metrics above • Taxes were reduced by $16.2M and $7.5M in F’05 and F’06 due to Deferred Tax Adjustments. • Excluding SPT and DTA, PA went from $84.8M to $83.3M in F’06

13 Latex Cost Graph … Latex Cost Graph … Updated Updated Latex Prices +7% in F’05 +73% in F’06 Malaysian ‘00 MYR (per wet kg) F’07 start price was MYR 6.81 Price on Oct 9 was MYR 4.53 – down 1/3rd from July 1 price Early latex price decline in F’07 a positive. However, given initial inventories (at higher F’06 prices) and previous forward purchases of 20% of F’07 demand – Ansell’s YTD average is ~ 5.5 MYR/wet kg Plus/minus .5 off a F’07 full year average cost of ~ 5.5 MYR/wet kg would, assuming no other changes, have an EPS impact of ~US2¢ • Notes: Wet Kg price divided by .6 equals ~ dry kg price. Source:  Malaysian Rubber Board Statistics 1.00 2.00 3.00 4.00 5.00 6.00 7.00 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06

14 Occupational Business Occupational Business 50% of Revenue and 56% of Segment EBIT 50% of Revenue and 56% of Segment EBIT 208.9 208.9 205.8 205.8 All Other All Other 14.3% 14.3% 14.9% 14.9% EBIT/Sales EBIT/Sales Margin Erosion / Mix Margin Erosion / Mix 60.7 60.7 61.0 61.0 Segment EBIT Segment EBIT +3.6% +3.6% 424.6 424.6 409.8 409.8 Sales Sales 81.9 81.9 81.3 81.3 Disposables Disposables VOL -9%, ASP +9% VOL -9%, ASP +9% 46.8 46.8 47.5 47.5 Knitted Knitted VOL +17% VOL +17% 87.0 87.0 75.2 75.2 HyFlex® HyFlex® F’06 F’06 F’05 F’05 $M $M Natural Latex 13% Synthetic 87% Strategy:  Continued concept of hand injury solutions - Guardian SM Continued emphasis on lower cost plants and outsourcing New products - expanding ergonomic technology advantage New channels and markets

15 Professional Business Professional Business 34% of Revenue and 27% of Segment EBIT 34% of Revenue and 27% of Segment EBIT VOL +25%, ASP lower due to mix 36.8 30.8 Synthetic VOL +10% (EMEA up), ASP flat 13.5 12.3 Powdered VOL +19%, ASP -6% 77.2 68.7 Exam:         PF 9.3 10.8 Other 10.0% 11.8% EBIT/Sales Latex costs / Exam Mix 29.0 32.7 Segment EBIT +4.6% 289.0 276.3 Sales Strong volume growth; all regions 16.2 4.1 14.7 3.6 Synthetic Other EMEA up, AM and AP down 60.2 65.3 Powdered EMEA and AP growth 71.7 70.1 Surgeons:  Branded PF F’06 F’05 $M Strategy: Pricing to recover latex cost increases New products to upgrade range (including synthetics) US surgical market share recovery Outsourcing commodity products instead of investment in new capacity Synthetic 21% Natural Latex 79%

16 Consumer Business Consumer Business 16% of Revenue and 17% of Segment EBIT 16% of Revenue and 17% of Segment EBIT 13.2% 13.2% 17.4% 17.4% EBIT/Sales EBIT/Sales US Retail Market Promotions US Retail Market Promotions 17.9 17.9 22.0 22.0 Segment EBIT Segment EBIT +7.5% +7.5% 135.5 135.5 126.0 126.0 Sales Sales 4Play & Supplements 4Play & Supplements 12.9 12.9 9.8 9.8 Other Other 19.0 19.0 19.2 19.2 HHG HHG Tenders up, AM Public Sector Down Tenders up, AM Public Sector Down 31.5 31.5 26.7 26.7 Bid Bid / / Public Public Jissbon $3.1M,  EU +8%, AM -14% 72.1 72.1 70.3 70.3 Condoms: Branded Condoms: Branded Retail Retail F’06 F’06 F’05 F’05 $M $M Strategy:   Strategy:   Recover USA Retail condoms Recover USA Retail condoms New products, new packaging, brand & line extensions New products, new packaging, brand & line extensions Use capacity through public sector and OEM supply Use capacity through public sector and OEM supply Expand geographic footprint and leverage global strength Expand geographic footprint and leverage global strength Synthetic 10% Natural Latex 90%

17 Ansell’s Financial Overview Ansell’s Financial Overview Ansell had mixed results in F’06 after several strong years, but continues to have solid fundamentals: Operationally: Sales growth was the highest in 8 years while EBIT was pulled down by latex Margins of “Non-latex” products, which account for 52% of sales, remained strong The Balance Sheet is healthy with low gearing and high interest coverage Free Cash Flow generation capability remains good EPS commitments were met, albeit with tax reduction benefits Structurally: The balanced capital management strategy continued to be executed. Surplus cash was distributed via higher dividends ($22.5M) and another share buy-back ($76.1M) A total of $307.8 M has now been distributed to our owners between F’04 – F’06 (80% via share buybacks) Ansell also made its first acquisition in 6 years spending $18.5M for 75% of Jissbon SPT, the last of the non-healthcare legacy businesses, was sold and $92M received

18 Strategic Focus Strategic Focus Doug Tough Doug Tough

19 Strategic Evolution Strategic Evolution From meeting multi-year Segment EBIT commitments to From meeting multi-year Segment EBIT commitments to advancing Ansell Growth Strategy for F’07 and Beyond advancing Ansell Growth Strategy for F’07 and Beyond Methodology: Methodology: F’06 Base Synthetic Surg Excite™ AlphaTEC™ Channels China China Mexico Mexico India India Russia Russia Technical Technical Partnerships Partnerships Other Other Jissbon Jissbon

20 Geographic Expansion Geographic Expansion • • Ansell’s growth in “Emerging” Ansell’s growth in “Emerging” markets markets Jissbon Acquisition – 10% Share of China Retail Condom market China Occupational – New Ansell trading company initiated Europe Emerging Markets – Strong Consumer & Occupational growth India – Occupational distribution set up Occupational +50% Occupational +50% Professional  +37% Professional  +37% Consumer      +10% Consumer      +10% Consumer      +66% Consumer      +66% Occupational +80% Occupational +80% Occupational +29% Occupational +29% Professional +60% Professional +60% China Russia & CIS Central & Eastern Europe Latin America South Africa Occupational +70% Occupational +70% Consumer      +15% Consumer      +15%

21 Ansell Takeaway Ansell Takeaway Solid and steadily growing company: Solid and steadily growing company: - - Organically Organically - - Geographically Geographically - - Acquisitively Acquisitively Cost components tightly managed Cost components tightly managed Diverse portfolio of brands, businesses, geographies Diverse portfolio of brands, businesses, geographies Strong financial position with investment and share buy-back Strong financial position with investment and share buy-back capability capability F’07 has started with good sales growth in all major areas F’07 has started with good sales growth in all major areas Despite this good sales start, and lower latex Despite this good sales start, and lower latex prices (July – prices (July – early early October), we are not revising F’07 EPS guidance, at this time, from October), we are not revising F’07 EPS guidance, at this time, from the US46¢ the US46¢ - - US50¢ US50¢ range, due to latex cost volatility. range, due to latex cost volatility.

22 ANSELL ANSELL LIMITED LIMITED

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 10, 2006